About this medicine
- Approved name
- Linco-Spectin 100 and associated names
- International non-proprietary name (INN) or common name
- lincomycin
- spectinomycin
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/V/A/088
- Type
- Article 34
Divergent decision referral: initiated in order to obtain harmonisation within the EU of the conditions of authorisation for products already authorised by Member States.
Key dates and outcomes
- Opinion date
- 10/04/2014
- EC decision date
- 11/07/2014